<DOC>
	<DOCNO>NCT00201851</DOCNO>
	<brief_summary>This trial test surgical oophorectomy ( removal ovary ) plus Tamoxifen , do different time menstrual cycle , adjuvant therapy invasive breast cancer 510 premenopausal woman Hormone Receptor-positive Breast Cancer . This study recruit hospital Philippines , Vietnam , Morocco .</brief_summary>
	<brief_title>Adjuvant Oophorectomy Tamoxifen Premenopausal Women With Hormone Receptor-Positive Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Open accrual Asia Female age 1850 , premenopausal regular cycle ( &gt; 2535 length ) fineneedle aspiration diagnosis Stage IIIIIA hormone receptor positive invasive breast cancer No prior radiation chemotherapy Must surgical candidate bilateral oophorectomy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Asian</keyword>
	<keyword>Premenopausal</keyword>
	<keyword>Women</keyword>
	<keyword>Oophorectomy</keyword>
</DOC>